...
首页> 外文期刊>RSC Advances >Novel isatin derivatives of podophyllotoxin: synthesis and cytotoxic evaluation against human leukaemia cancer cells as potent anti-MDR agents
【24h】

Novel isatin derivatives of podophyllotoxin: synthesis and cytotoxic evaluation against human leukaemia cancer cells as potent anti-MDR agents

机译:鬼臼毒素的新型Isatin衍生物:作为有效的抗MDR剂,对人白血病癌细胞的合成和细胞毒性评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Multidrug resistance (MDR) is a major cause of chemotherapy failure in cancer therapy. In this study, a series of isatin derivatives of podophyllotoxin were synthesized and evaluated for their cytotoxic activity against human leukemia K562 cells and adriamycin-resistant K562/ADR cells using CCK-8 assay in vitro. All derivatives exhibited higher potency of antiproliferative effects against K562 and K562/ADR cell lines than the control drugs etoposide and adriamycin at nanomolar range, and markedly reduced the resistant factors. Among them, the cytotoxicities exhibited by compounds 8c and 8i were found to comparable or more effective than podophyllotoxin. In particular, 8c exhibited significant cytotoxicity against resistance K562/ADR cells with IC50 value of 0.067 +/- 0.010 mu M. Furthermore, cell cycle analysis revealed that 8c could remarkably induce K562/ADR cell cycle arrest in the G2/M phase. Meanwhile, the effect of 8c on apoptosis inducing was also observed notably by flow cytometry and Hoechst 33342 staining. Moreover, western blotting analysis suggested that 8c had the potential to overcome the resistance of K562/ADR cells by down-regulating the expression levels of multi-drug resistance-related proteins, such as Pgp, MRP-1 and GST-pi.
机译:多药耐药性(MDR)是癌症治疗中化疗失败的主要原因。在这项研究中,合成了一系列鬼臼毒素的伊斯汀衍生物,并通过体外CCK-8分析评估了它们对人白血病K562细胞和抗阿霉素K562 / ADR细胞的细胞毒活性。在纳摩尔范围内,所有衍生物均比对照药物依托泊苷和阿霉素具有更高的针对K562和K562 / ADR细胞系的抗增殖作用,并显着降低了耐药因子。其中,发现化合物8c和8i表现出的细胞毒性与鬼臼毒素相当或更有效。特别地,8c对K562 / ADR耐药细胞表现出显着的细胞毒性,IC50值为0.067 +/- 0.010μM。此外,细胞周期分析显示8c可以显着诱导K562 / ADR细胞周期阻滞于G2 / M期。同时,还通过流式细胞术和Hoechst 33342染色观察到了8c对细胞凋亡的诱导作用。而且,蛋白质印迹分析表明8c具有通过下调多种与药物抗药性相关的蛋白如Pgp,MRP-1和GST-pi的表达水平来克服K562 / ADR细胞的抗药性的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号